Orig3n Introduces New Runtm DNA Test

BOSTON, July 5, 2018 /PRNewswire/ -- Orig3n, Inc., a Boston-based biotech company pioneering the future of wellness through genetics and regenerative medicine research, today announced the national launch of a new Runtm DNA Test to give runners the insight they need to reach the finish line faster. The $99 test will now allow individuals to learn about four key categories: Nutrition, Training, Endurance and Recovery associated with running performance.

"We are so excited to introduce the Runtm DNA Test to the public," said Robin Smith, co-founder and CEO of Orig3n. "DNA is a valuable tool for assessing fitness potential and now everyone can discover insights into their own running potential ? and learn how to boost their performance."

Featuring 24 genes, the Runtm DNA Test premiered in May during the annual Alaska Airlines Bay to Breakers event in San Francisco, at the Orig3n Health and Wellness Expo where thousands of participants gave the Runtm DNA Explorer test positive reviews.

The test answers key questions for runners to help them better train, including:

• Are you more likely to be built for speed ? or endurance?
• Does your body have a tendency to bulk up ? or slim down?
• How quickly might you bounce back after a run?

"Our new Runtm DNA Test was so well-received during race weekend that we decided to accelerate the launch nationally. It's about making fitness choices that are more in line with your genes and your body ? simple as that," said Smith.

Runtm DNA joins Orig3n's portfolio of direct to consumer DNA tests that also include Nutrition, Fitness and Metabolism tests, among others. All Orig3n DNA test reports are delivered via a mobile app exclusively on the Apple app store or online to enable easy integration into individuals' active lifestyles. For more information on ordering, please visit: orig3n.com/run.

About Orig3n, Inc. 
Orig3n exists at the intersection of biological science and emerging technology on a mission to create a better tomorrow for the future of medicine. As part of the mission to democratize health, Orig3n empowers people by providing consumers direct, affordable access to information about their genes to help them make educated, proactive and personalized choices that may impact their well-being. That business enables Orig3n to invest in breakthrough cell therapy R&D by utilizing cutting-edge cellular science to develop personalized therapies for repairing tissue damage and disease. For more information, visit www.orig3n.com/our-mission/.

Disclaimer: These products are not a diagnostic test and cannot predict your future health. All data, text, images, and graphics associated with this product are for informational purposes only. Use of this product is not intended to be a substitute for professional medical judgment. Please consult your doctor if you have a question about a medical issue.

Media Contact:
Angela Salerno-Robin
[email protected]
(312) 233-1243

SOURCE Orig3n, Inc.